Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00079313
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2004-03-08
Brief Title:
Imatinib GleevecRegistered Trademark to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Myelogenous Leukemia |
| Chronic Myelomonocytic Leukemia |